{"id":"https://openalex.org/W3138977263","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4557","title":"FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer","display_name":"FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer","publication_year":2021,"publication_date":"2021-03-22","ids":{"openalex":"https://openalex.org/W3138977263","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4557","mag":"3138977263","pmid":"https://pubmed.ncbi.nlm.nih.gov/33753456","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8570919"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-20-4557","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4557","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-4557","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/27/16/4478/3083977/4478.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/27/16/4478/3083977/4478.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073413471","display_name":"Preeti Narayan","orcid":"https://orcid.org/0000-0003-0825-9087","observed_orcids":["https://orcid.org/0000-0003-0825-9087"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Preeti Narayan","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030426478","display_name":"Christy L. Osgood","orcid":"https://orcid.org/0000-0001-7450-9342","observed_orcids":["https://orcid.org/0000-0001-7450-9342"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christy L. Osgood","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035436218","display_name":"Harpreet Singh","orcid":"https://orcid.org/0000-0003-1526-0916","observed_orcids":["https://orcid.org/0000-0003-1526-0916"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harpreet Singh","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020171435","display_name":"Haw-Jyh Chiu","orcid":"https://orcid.org/0009-0004-4814-6110","observed_orcids":["https://orcid.org/0009-0004-4814-6110"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haw-Jyh Chiu","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077762257","display_name":"Tiffany K. Ricks","orcid":"https://orcid.org/0000-0003-2026-0996","observed_orcids":["https://orcid.org/0000-0003-2026-0996"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany K. Ricks","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021532388","display_name":"Edwin C.Y. Chow","orcid":"https://orcid.org/0009-0004-8281-0994","observed_orcids":["https://orcid.org/0009-0004-8281-0994","https://orcid.org/0009-0004-0008-1549"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edwin Chiu Yuen Chow","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086876495","display_name":"Junshan Qiu","orcid":"https://orcid.org/0000-0003-3629-1703","observed_orcids":["https://orcid.org/0000-0003-3629-1703"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Junshan Qiu","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pengfei Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pengfei Song","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101594099","display_name":"Jingyu Yu","orcid":"https://orcid.org/0009-0006-6249-7907","observed_orcids":["https://orcid.org/0009-0006-6249-7907"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingyu Yu","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009473372","display_name":"Frances Namuswe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances Namuswe","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089126800","display_name":"Maria Guiterrez-Lugo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Guiterrez-Lugo","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042471290","display_name":"Sherry Hou","orcid":"https://orcid.org/0009-0000-5883-5164","observed_orcids":["https://orcid.org/0009-0000-5883-5164"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherry Hou","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050956552","display_name":"William F. Pierce","orcid":"https://orcid.org/0000-0002-3411-7720","observed_orcids":["https://orcid.org/0000-0002-3411-7720"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William F. Pierce","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074097054","display_name":"Kirsten B. Goldberg","orcid":"https://orcid.org/0000-0001-8659-1240","observed_orcids":["https://orcid.org/0000-0001-8659-1240"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirsten B. Goldberg","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":"https://orcid.org/0000-0001-8659-1240","affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043067852","display_name":"Shenghui W. Tang","orcid":"https://orcid.org/0000-0002-0437-665X","observed_orcids":["https://orcid.org/0000-0002-0437-665X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shenghui Tang","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062916090","display_name":"Laleh Amiri\u2010Kordestani","orcid":"https://orcid.org/0000-0002-0056-5437","observed_orcids":["https://orcid.org/0000-0002-0056-5437"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laleh Amiri-Kordestani","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069297078","display_name":"Marc Robert Theoret","orcid":"https://orcid.org/0000-0003-4973-5297","observed_orcids":["https://orcid.org/0000-0003-4973-5297"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc R. Theoret","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051520990","display_name":"Richard Pazdur","orcid":"https://orcid.org/0000-0002-4771-9923","observed_orcids":["https://orcid.org/0000-0002-4771-9923"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Pazdur","raw_affiliation_strings":["2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004000071","display_name":"Julia A. Beaver","orcid":"https://orcid.org/0000-0002-0725-2863","observed_orcids":["https://orcid.org/0000-0002-0725-2863"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia A. Beaver","raw_affiliation_strings":["1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073413471"],"corresponding_institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"],"apc_list":null,"apc_paid":null,"fwci":10.056,"has_fulltext":true,"cited_by_count":171,"citation_normalized_percentile":{"value":0.99154159,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"27","issue":"16","first_page":"4478","last_page":"4485"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.8019999861717224},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.675000011920929},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9070000052452087},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.847000002861023},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8539999723434448},{"id":"https://openalex.org/keywords/left-ventricular-dysfunction","display_name":"left ventricular dysfunction","score":0.9879999756813049},{"id":"https://openalex.org/keywords/accelerated-approval","display_name":"accelerated approval","score":0.5210000276565552},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6489999890327454},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.902999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9149600267410278},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.675356388092041},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6030141711235046},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5377933979034424},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.520555317401886},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5119010210037231},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4751291573047638},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.47296375036239624},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4659520089626312},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43506288528442383},{"id":"https://openalex.org/C2781112942","wikidata":"https://www.wikidata.org/wiki/Q178436","display_name":"Constipation","level":2,"score":0.42865002155303955},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4223948121070862},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3709717094898224},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33374089002609253},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.23710331320762634},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.1986975073814392},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12975648045539856}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-20-4557","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4557","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-4557","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/27/16/4478/3083977/4478.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:33753456","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33753456","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8570919","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8570919","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-20-4557","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4557","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-4557","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/27/16/4478/3083977/4478.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3050811832","display_name":null,"funder_award_id":"FD999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3138977263.pdf","grobid_xml":"https://content.openalex.org/works/W3138977263.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2110444464","https://openalex.org/W2137228442","https://openalex.org/W2155333216","https://openalex.org/W2159427817","https://openalex.org/W2159967578","https://openalex.org/W2314772071","https://openalex.org/W2810369514","https://openalex.org/W2889646458","https://openalex.org/W2996630100","https://openalex.org/W3005585857","https://openalex.org/W3018222852"],"related_works":["https://openalex.org/W4249794066","https://openalex.org/W4400383364","https://openalex.org/W4320482645","https://openalex.org/W4361256061","https://openalex.org/W3130727913","https://openalex.org/W4237129408","https://openalex.org/W3024700745","https://openalex.org/W4367668991","https://openalex.org/W2995038129","https://openalex.org/W3216162050"],"abstract_inverted_index":{"On":[0],"December":[1],"20,":[2],"2019,":[3],"the":[4,19,41,92,124,186,194,200],"FDA":[5],"granted":[6],"accelerated":[7,195],"approval":[8,196],"to":[9,90],"fam-trastuzumab":[10],"deruxtecan-nxki":[11],"[DS-8201a;":[12],"T-DXd;":[13],"tradename":[14],"ENHERTU":[15],"(Daiichi":[16],"Sankyo)]":[17],"for":[18,199],"treatment":[20],"of":[21,95,103,188,197],"adult":[22],"patients":[23,115,141],"with":[24,53,143],"unresectable":[25],"or":[26,35,151],"metastatic":[27,42],"HER2-positive":[28],"breast":[29],"cancer":[30],"who":[31,87],"have":[32],"received":[33],"two":[34],"more":[36],"prior":[37],"anti-HER2-based":[38],"regimens":[39],"in":[40,64,84,112,140,166],"setting.":[43],"Approval":[44],"was":[45,66,116,127,138],"based":[46,71,109],"on":[47,72,110],"data":[48,56,192],"from":[49,57],"study":[50,58],"DS8201-A-U201":[51],"(DESTINY-Breast01)":[52],"supportive":[54],"safety":[55,191],"DS8201-A-J101.":[59],"The":[60,106],"primary":[61],"efficacy":[62,189],"endpoint":[63],"DESTINY-Breast01":[65],"overall":[67],"response":[68,104],"rate":[69],"(ORR)":[70],"confirmed":[73,107],"responses":[74],"by":[75],"blinded":[76],"independent":[77],"central":[78],"review":[79],"(ICR)":[80],"using":[81],"RECIST":[82],"v1.1":[83],"all":[85],"participants":[86],"were":[88,160,173],"assigned":[89],"receive":[91],"recommended":[93],"dose":[94],"5.4":[96],"mg/kg":[97],"while":[98],"secondary":[99],"endpoints":[100],"included":[101,161],"duration":[102],"(DoR).":[105],"ORR":[108],"ICR":[111],"these":[113],"184":[114],"60.3%":[117],"[95%":[118],"confidence":[119],"interval":[120],"(CI):":[121],"52.9-67.4]":[122],"and":[123,145,156,164,183,190],"median":[125],"DoR":[126],"14.8":[128],"months":[129],"(95%":[130],"CI:":[131],"13.8-16.9).":[132],"Interstitial":[133],"lung":[134],"disease,":[135],"including":[136],"pneumonitis,":[137],"experienced":[139],"treated":[142],"T-DXd":[144,198],"can":[146],"be":[147],"severe,":[148],"life":[149],"threatening,":[150],"fatal.":[152],"In":[153],"addition,":[154],"neutropenia":[155],"left":[157],"ventricular":[158],"dysfunction":[159],"as":[162],"Warnings":[163],"Precautions":[165],"labeling.":[167],"Other":[168],"important":[169],"common":[170],"adverse":[171],"reactions":[172],"nausea,":[174],"fatigue,":[175],"vomiting,":[176],"alopecia,":[177],"constipation,":[178],"decreased":[179],"appetite,":[180],"anemia,":[181],"diarrhea,":[182],"thrombocytopenia.":[184],"Overall,":[185],"totality":[187],"supported":[193],"intended":[201],"indication.":[202]},"counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":40},{"year":2024,"cited_by_count":43},{"year":2023,"cited_by_count":34},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-29T00:00:00"}